Evidence map›Paper›PMID 26086089›Full record

ArticlePloS one2015

The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression.

Baligh R Yehia, Alisa J Stephens-Shields, John A Fleishman, Stephen A Berry, Allison L Agwu, Joshua P Metlay, Richard D Moore, W Christopher Mathews, Ank Nijhawan, Richard Rutstein and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02692027 (Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial), which is not on this map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02692027 phase3completednot on this mapstarted 2016, after this paper: background citation

Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial

TypeinterventionalSponsorSwiss Tropical & Public Health InstituteRan2016 to 2018Enrolled276ConditionsHIV InfectionArmsSame-day ART initiation, Standard of care
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV Viral Re-Suppression on Second-Line ART in Southern Zimbabwe.International journal of environmental research and public health · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Baligh R YehiaDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, United States of America; Center for Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Alisa J Stephens-ShieldsCenter for Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
John A FleishmanCenter for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD, United States of America.
Stephen A BerryDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Allison L AgwuDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Joshua P MetlayGeneral Medicine Division, Massachusetts General Hospital, Boston, MA, United States of America.
Richard D MooreDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
W Christopher MathewsDepartment of Medicine, University of California San Diego, San Diego, CA, United States of America.
Ank NijhawanDepartment of Medicine, University of Texas Southwestern, Dallas, TX, United States of America.
Richard RutsteinDivision of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Aditya H GaurDepartment of Infectious Diseases, St. Jude's Children's Hospital, Memphis, TN, United States of America.
Kelly A GeboDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
HIV Research Network
Johns Hopkins Medicine · USUniversity of Pennsylvania · USAgency for Healthcare Research and Quality · USChildren's Hospital of Philadelphia · USJohns Hopkins University · USMassachusetts General Hospital · USSt. Jude Children's Research Hospital · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Diego · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Universal Screening of HIV-Infected Persons for Gonorrhea and ChlamydiaK23AI084854 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BERRY, STEPHEN ARTHUR · 2010 to 2014
$671k
Evaluating Patient Retention in HIV CareK23MH097647 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI YEHIA, BALIGH RAMZI · 2012 to 2013
$361k
NIAID NIH HHS K23 AI084854NIAID NIH HHS K23-AI084854NIAID NIH HHS P30 AI045008NIAID NIH HHS P30 AI094189NIMH NIH HHS K23 MH097647NIMH NIH HHS K23-MH097647PHS HHS HHSA290201100007C
6 · The paper itself

Abstract

backgroundThe HIV care continuum (diagnosis, linkage to care, retention in care, receipt of antiretroviral therapy (ART), viral suppression) has been used to identify opportunities for improving the delivery of HIV care. Continuum steps are typically calculated in a conditional manner, with the number of persons completing the prior step serving as the base population for the next step. This approach may underestimate the prevalence of viral suppression by excluding patients who are suppressed but do not meet standard definitions of retention in care. Understanding how retention in care and viral suppression interact and change over time may improve our ability to intervene on these steps in the continuum.

methodsWe followed 17,140 patients at 11 U.S. HIV clinics between 2010-2012. For each calendar year, patients were classified into one of five categories: (1) retained/suppressed, (2) retained/not-suppressed, (3) not-retained/suppressed, (4) not-retained/not-suppressed, and (5) lost to follow-up (for calendar years 2011 and 2012 only). Retained individuals were those completing ≥ 2 HIV medical visits separated by ≥ 90 days in the year. Persons not retained completed ≥ 1 HIV medical visit during the year, but did not meet the retention definition. Persons lost to follow-up had no HIV medical visits in the year. HIV viral suppression was defined as HIV-1 RNA ≤ 200 copies/mL at the last measure in the year. Multinomial logistic regression was used to determine the probability of patients' transitioning between retention/suppression categories from 2010 to 2011 and 2010 to 2012, adjusting for age, sex, race/ethnicity, HIV risk factor, insurance status, CD4 count, and use of ART.

resultsOverall, 65.8% of patients were retained/suppressed, 17.4% retained/not-suppressed, 10.0% not-retained/suppressed, and 6.8% not-retained/not-suppressed in 2010. 59.5% of patients maintained the same status in 2011 (kappa=0.458) and 53.3% maintained the same status in 2012 (kappa=0.437).

conclusionsNot counting patients not-retained/suppressed as virally suppressed, as is commonly done in the HIV care continuum, underestimated the proportion suppressed by 13%. Applying the care continuum in a longitudinal manner will enhance its utility.

Indexed as

CD4 Lymphocyte CountContinuity of Patient CareViral LoadAdolescentAdultAnti-HIV AgentsFemaleHIV-1HIV InfectionsHumansInsurance CoverageLost to Follow-UpMaleMiddle AgedUnited StatesYoung AdultAnti-HIV Agents

Identifiers

PMID26086089
PMCPMC4473034
OpenAlexW636206740

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.